Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...
Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback